Richter Gedeon's Q2 mixed; net profit up
Richter Gedeon, Hungary's largest pharmaceutical manufacturer, reported a 45.3% increase in its second quarter net profit, which was higher than analysts had anticipated, the company announced today.
The operating profit, reported at HUF 10.560 bln, was below analysts expectations. The company said this was due to disappointing sales in Russia and Ukraine.
"Richter said its domestic market had stabilised, but revenue from Russia fell by 25.3 percent in euro terms year-on-year in the first half, while sales to Ukraine were down 23.2 percent," according to Reuters.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.